Advances in antihypertensive therapy: Non-peptide angiotensin II receptor antagonists as potent therapeutic agents Julian SmithAmal WahhabGraham J. Moore OriginalPaper Pages: 169 - 174
Interactions of angiotensin II with membranes using a combination of differential scanning calorimetry and 31P NMR spectroscopy Thomas MavromoustakosEfthimia TheodoropoulouAlexandros Makriyannis OriginalPaper Pages: 175 - 180
Influence of sarmesin on the cardiac and vascular actions of angiotensin II Stefan MihailescuJohn M. MatsoukasCristina Alecu-Parvu OriginalPaper Pages: 181 - 184
Influence of sarmesin on some dopamine-related types of behaviour Vasil GeorgievJohn M. MatsoukasIvan Todorov OriginalPaper Pages: 185 - 190
Biological activity of the novel cyclic angiotensin II analogue [Sar1,Lys3,Glu5]ANG II Demetrios V. VlahakosJohn M. MatsoukasDimitrios Th. Kremastinos OriginalPaper Pages: 191 - 194
Conformational analysis of cyclic angiotensin II analogues Juris BalodisAlexander Golbraikh OriginalPaper Pages: 195 - 199
Conformational and antigenic properties of SRYD-containing peptide analogues of Leishmania gp63 adhesion site Maria Sakarellos-DaitsiotisEugenia Panou-PomonisVassilios Tsikaris OriginalPaper Pages: 200 - 208
Superimposition of potent non-peptide AT1 receptor antagonists with angiotensin II Efthimia TheodoropoulouThomas MavromoustakosJulian Smith OriginalPaper Pages: 209 - 216
Structural studies with weak oxytocin antagonists Nikos AssimomytisVassiliki MagafaJirina Slaninova OriginalPaper Pages: 217 - 220
Intracoronary and systemic release of the atrial natriuretic factor and cyclic-guanosine monophosphate during coronary angioplasty Efstathios K. IliodromitisGeorge K. KaravoliasDimitrios Th. Kremastinos OriginalPaper Pages: 221 - 226
Inhibition of TRAP-induced angiogenesis by the tripeptide Phe-Pro-Arg, a thrombin-receptor-derived peptide analogue Michael E. MaragoudakisEva Pipili-SynetosJohn M. Matsoukas OriginalPaper Pages: 227 - 232
Synthesis and activities of cyclic thrombin-receptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence containing d-Phe and/or d-Arg Dimitris PanagiotopoulosJohn M. MatsoukasMorley D. Hollenberg OriginalPaper Pages: 233 - 240
MPLC purification of protected peptide fragments Dimitrios GatosChryssoula TzavaraKleomenis Barlos OriginalPaper Pages: 241 - 246
Danazol versus [d-Trp6]GnRH agonist for the management of infertility due to atypical endometriosis Vasilis A. TzingounisEmmanuel Cardamakis OriginalPaper Pages: 247 - 251
Molecular basis of angiotensin- and thrombin-induced endothelium-independent vasoconstriction and proliferation Ludmila K. Polevaya OriginalPaper Pages: 252 - 256
Design and synthesis of a gonadotropin-releasing hormone (GnRH) analogue, [Tyr(OMe)5,d-Glu6,Aze9]GnRH: Receptor binding, gonadotropin release and ovulation studies Maria KeramidaJohn M. MatsoukasHamid R. Habibi OriginalPaper Pages: 257 - 262
